Showing results (21-30 of 123) with videos related to

Sort By:
Pageof 13
Oncology Letters|August 7, 2012
Small-cell lung carcinoma with long-term survival: A case reportKazumi Nishino, Fumio Imamura, Toru Kumagai, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 18, 2003
Role of extracellular subdomains of p185c-neu and the epidermal growth factor receptor in ligand-independent association and transactivationToru Kumagai, Makoto Katsumata, Akihiro Hasegawa, et al.
Internal Medicine (Tokyo, Japan)|May 16, 2014
Porous diaphragm syndrome with repeated rapid accumulation of pleural effusionTakako Okuyama, Madoka Kimura, Junji Uchida, et al.
Respiratory Medicine Case Reports|August 4, 2015
Pneumothorax triggered by the combination of gefitinib and amrubicin and treated with endobronchial silicone spigotsFumio Imamura, Norio Okamoto, Takako Inoue, et al.
Oncotarget|October 7, 2016
Early responses of EGFR circulating tumor DNA to EGFR tyrosine kinase inhibitors in lung cancer treatmentFumio Imamura, Junji Uchida, Yoji Kukita, et al.
Scientific Reports|December 10, 2016
Transient appearance of circulating tumor DNA associated with de novo treatmentKikuya Kato, Junji Uchida, Yoji Kukita, et al.
Clinical Lung Cancer|March 25, 2014
Novel chemoradiotherapy with concomitant boost thoracic radiation and concurrent cisplatin and vinorelbine for stage IIIA and IIIB non-small-cell lung cancerFumio Imamura, Koji Konishi, Junji Uchida, et al.
Cancer Science|December 19, 2015
Dynamics of circulating tumor DNA represented by the activating and resistant mutations in epidermal growth factor receptor tyrosine kinase inhibitor treatmentJunji Uchida, Fumio Imamura, Yoji Kukita, et al.
Lung Cancer (Amsterdam, Netherlands)|March 15, 2016
Monitoring of treatment responses and clonal evolution of tumor cells by circulating tumor DNA of heterogeneous mutant EGFR genes in lung cancerFumio Imamura, Junji Uchida, Yoji Kukita, et al.
Scientific Reports|July 7, 2016
Numerical indices based on circulating tumor DNA for the evaluation of therapeutic response and disease progression in lung cancer patientsKikuya Kato, Junji Uchida, Yoji Kukita, et al.
Pageof 13